The performance of the Swedish krona negatively affected the earnings of PACS and digital mammography developer Sectra in its third fiscal quarter of 2011.
For the quarter (end-January 31), the company's net sales rose 14% to 229.1 million kronor ($36 million U.S.), compared with 201.2 million kronor ($31.6 million U.S.) in the third quarter of fiscal 2010. The company also posted an operating loss of 5.9 million kronor ($926,000 U.S.), compared with a loss of 2.5 million kronor ($393,000 U.S.) in the same quarter a year ago.
Net sales for the nine-month period rose 15% to 682.6 million kronor ($107.3 million U.S.), compared with 592.9 million kronor ($93.1 million U.S.) in the same period of 2010. The firm's operating profit was 1.8 million kronor ($283,000 U.S.), compared with 14 million kronor ($2.2 million U.S.) in the same period last year. The result after net financial items was a loss of 9.7 million kronor ($1.5 million U.S.). Exchange-rate fluctuations had a negative impact of 12.4 million kronor ($1.9 million U.S.), the company said.
Sectra recently announced that it has entered the Canadian mammography market with the approval of its Sectra MicroDose system.
